Names | |
---|---|
IUPAC name
Sodium salicylate
|
|
Other names
Salsonin, Monosodium salicylate, Sodium o-hydroxybenzoate, Sodium 2-hydroxybenzoate, Salicylic acid sodium salt, Monosodium 2-hydroxybenzoate, Diuratin
|
|
Identifiers | |
54-21-7 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL447868 |
ChemSpider | 5689 |
DrugBank | DB01398 |
ECHA InfoCard | 100.000.181 |
EC Number | 200-198-0 |
KEGG | D00566 |
PubChem | 16760658 |
RTECS number | VO5075000 |
UNII | WIQ1H85SYP |
|
|
|
|
Properties | |
C7H5NaO3 | |
Molar mass | 160.10 g·mol−1 |
Appearance | white crystals |
Melting point | 200 °C (392 °F; 473 K) |
25.08 g/100 mL (-1.5 °C) 107.9 g/100 mL (15 °C) 124.6 g/100 mL (25 °C) 141.8 g/100 mL (78.5 °C) 179 g/100 g (114 °C) |
|
Solubility | soluble in glycerol, 1,4-Dioxane, alcohol |
Solubility in methanol | 26.28 g/100 g (15 °C) 34.73 g/100 g (67.2 °C) |
Pharmacology | |
N02BA04 (WHO) | |
Hazards | |
Main hazards | Harmful |
GHS pictograms | |
GHS signal word | Warning |
H314, H331, H400 | |
P210, P261, P273, P280, P305+351+338, P310 | |
EU classification (DSD)
|
Xn |
R-phrases | R22, R36/37/38 |
S-phrases | S24/25, S26, S36/37/39 |
Eye hazard | Irritant |
NFPA 704 | |
250 °C (482 °F; 523 K) | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
930 mg/kg (rats, oral) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
what is ?) | (|
Infobox references | |
Sodium salicylate is a sodium salt of salicylic acid. It can be prepared from sodium phenolate and carbon dioxide under higher temperature and pressure. Historically, it has been synthesized from methyl salicylate (found in wintergreen plants or the bark of sweet birch tree) by reacting it with an excess of sodium hydroxide and heating it under reflux.
Sodium salicylate is of the salicylate family and this compound is known to trigger Reye's Syndrome in children and adults, usually following a viral infection such as influenza or chicken pox. Products containing such salicylates should not be given to children under the age of 19.
It is used in medicine as an analgesic and antipyretic. Sodium salicylate also acts as non-steroidal anti-inflammatory drug (NSAID), and induces apoptosis in cancer cells and also necrosis. It is also a potential replacement for aspirin for people sensitive to it. It may also be used as a phosphor for the detection of vacuum ultraviolet radiation and electrons.